Jiete Biotech (688026.SH) announced 2024 annual results, with net profit of 72.19 million yuan to mother, an increase of 107.51% over the previous year

Zhitongcaijing · 04/15 13:09

According to Zhitong Finance App News, Jet Biotech (688026.SH) disclosed its 2024 annual report. During the reporting period, the company achieved revenue of 559 million yuan, an increase of 20.63% year on year; net profit to mother was 72.19 million yuan, up 107.51% year on year; after deducting non-net profit of 67.75 million yuan, an increase of 113.15% year on year; basic earnings per share were 0.52 yuan. The company plans to distribute a cash dividend of 0.73 yuan (tax included) for every 10 shares to all shareholders.